Sat, Aug 2, 2014, 2:09 AM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

BioMarin Pharmaceutical (BMRN) Message Board

  • cholee65 cholee65 Sep 12, 2011 8:52 AM Flag

    Amgen bought Oncovex for $1 billion this year.

    Amgen recently bought cancer darling Oncovex for $1 Billion. About seven years ago Genzyme
    bought San Antonio biotech Ilex Oncology for $1 Billion dollars too. It looks like if you come
    up with the good data $1 billion is the magic buyout number.If you look into the roots of who
    really created Ilex Oncology. You will find the star was Alex Weis the co-founder he was
    their scientist; he brought in two awesome drugs from Sterling in San Antonio. Now he's at it again
    with Oncovista down in San Antonio. He has a tiny market cap of $12 million and $65 million in
    milestones over next 36 months potentially. And, two drug compounds with market potential of $1.35 billion.
    If OVIT repeats Ilex Oncology's success it has 100X upside potential.

    Watch the CEO talk.. http://www.youtube.com/watch?v=Mh_RZMh-xcU

    the CEO is top notch and if their Adult Leukemia drug could have been approved for Hairy Cell Leukemia.
    However, the market was to small. I think this stock is going to be a major home run.
    This has tremendous upside potential given it's market cap is so small compared
    to all other cancer stocks listed.

 
BMRN
61.95+0.13(+0.21%)Aug 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Berkshire Hathaway Inc.
NYSEFri, Aug 1, 2014 4:02 PM EDT
Tesla Motors, Inc.
NasdaqGSFri, Aug 1, 2014 4:00 PM EDT